US FDA Cell And Gene Therapy Regulation “Must Evolve,” OTP Acting Director Kumar Says

 
• By Michael McCaughan
  
Some challenges with cell and gene therapies require collaborative solutions, Acting OTP Director Vijay Kumar said. (Shutterstock)

More from Cell & Gene Therapies

More from United States